627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer

• Keegan Cooke,
• Jinghui Zhan,
• Juan Estrada,
• Marie-Anne Damiette Smit,
• Aditya Shetty,
• Jonathan Werner,
• Fei Lee

Affiliations

Keegan Cooke

Aff1 grid.417886.40000000106575612Amgen Thousand Oaks CA USA

Jinghui Zhan

Aff1 grid.417886.40000000106575612Amgen Thousand Oaks CA USA

Juan Estrada

Aff4 grid.417886.40000000106575612Amgen Inc. Thousand Oaks CA USA

Marie-Anne Damiette Smit

Amgen Inc, Thousand Oaks, California, USA

Aditya Shetty

17Amgen Inc., Thousand Oaks, CA, USA

Jonathan Werner

Amgen, Thousand Oaks, CA, USA

Fei Lee

Amgen, Thousand Oaks, CA, USA